Premium Nahrungsergänzungsmittel | artgerecht

Quercetin Biokinetics – Absorption and Body Distribution

Quercetin biokinetics describes how the plant-derived compound quercetin is absorbed, distributed, metabolized, and eliminated in the human body.

Regular tips about health Regular tips about health

Things worth knowing about "Quercetin Biokinetics"

Quercetin biokinetics describes how the plant-derived compound quercetin is absorbed, distributed, metabolized, and eliminated in the human body.

What Is Quercetin Biokinetics?

Quercetin biokinetics is a branch of pharmacokinetics that studies the behavior of the plant polyphenol quercetin inside the human body. It covers the four classical pharmacokinetic phases: absorption, distribution, metabolism, and elimination -- collectively referred to as ADME. Understanding these processes is essential for assessing the bioavailability and the actual health-related effectiveness of quercetin.

Absorption

In food, quercetin is predominantly found as a glycoside -- bound to sugar molecules. These glycosides must first be hydrolyzed by bacterial enzymes and intestinal glycosidases before the free aglycone or its metabolites can be taken up by intestinal cells.

The bioavailability of quercetin is generally moderate to low and varies widely depending on the food source, preparation method, and individual gut microbiota.
Quercetin rutinoside (rutin) has a significantly lower absorption rate than quercetin glucoside (e.g., from onions).
Lipid-based formulations and fat-soluble delivery systems can substantially enhance uptake.

Distribution

After absorption, quercetin enters the bloodstream in conjugated form (as glucuronides, sulfates, or methyl derivatives). In the blood, it is largely bound to plasma proteins, particularly albumin. Distribution into various tissues -- including the liver, lungs, kidneys, and intestinal tissue -- has been documented, and limited penetration of the blood-brain barrier is also discussed in the scientific literature.

Metabolism

Quercetin undergoes extensive first-pass metabolism in the liver and significant intestinal biotransformation. This produces several conjugate types:

Glucuronides: Formed by UDP-glucuronosyltransferases (UGTs) in the gut and liver.
Sulfates: Produced by sulfotransferases (SULTs).
Methyl derivatives: Generated by catechol-O-methyltransferase (COMT), yielding compounds such as isorhamnetin and tamarixetin.

In the large intestine, quercetin is further broken down by the gut microbiome into smaller phenolic compounds such as protocatechuic acid and 3,4-dihydroxyphenylacetic acid. These metabolites may themselves be biologically active.

Elimination

Quercetin and its metabolites are excreted primarily via:

The urine (renal excretion of conjugated forms)
The bile (biliary excretion with enterohepatic recirculation)
The feces (unabsorbed fractions and microbial degradation products)

The plasma half-life of quercetin ranges from approximately 11 to 28 hours depending on the study and formulation, indicating a moderately long residence time in the body.

Factors Influencing Bioavailability

Several factors can significantly affect the biokinetics of quercetin:

Food matrix: Co-ingestion with dietary fat or other food components improves absorption.
Formulation and delivery system: Nanoparticles, liposomes, or phytosome formulations markedly increase bioavailability.
Individual gut microbiota: The composition of the microbiome determines which metabolites are produced in the colon.
Genetic factors: Polymorphisms in UGT, SULT, and COMT genes influence the rate and pattern of metabolism.
Combination with other substances: Bromelain and vitamin C are considered absorption enhancers.

Clinical Relevance

A thorough understanding of quercetin biokinetics is essential for evaluating its anti-inflammatory, antioxidant, and antiviral properties. Therapeutically relevant effects can only be expected when sufficiently bioavailable concentrations are reached in the target tissue. Current research focuses on optimized formulations to enhance the clinical efficacy of quercetin.

References

Manach C. et al. - Polyphenols: food sources and bioavailability. American Journal of Clinical Nutrition, 2004; 79(5): 727-747.
Bischoff S.C. - Quercetin: potentials in the prevention and therapy of disease. Current Opinion in Clinical Nutrition and Metabolic Care, 2008; 11(6): 733-740.
European Food Safety Authority (EFSA) - Scientific opinion on the safety of quercetin as a food supplement. EFSA Journal, 2011; 9(7): 2279.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.